EC
HARP

EcoR1 Capital’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

EcoR1 Capital’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-90,855
Closed -$13.4M – 62
2019
Q4 		$13.4M Sell
90,855
-55,487
-38% -$8.42M 1.21% 21
2019
Q3 		$20M Buy
146,342
+11,500
+9% +$1.62M 2.52% 13
2019
Q2 		$17.5M Buy
134,842
+1,200
+0.9% +$139K 1.77% 15
2019
Q1 		$12.7M Buy
+133,642
New +$17.6M 1.17% 23

Other funds holding HARP

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

EcoR1 Capital's HARP Position: Q1 2020 in Review

EcoR1 Capital sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2020, closing a stake of 90,855 shares — an estimated $13.4M sold.

EcoR1 Capital first reported a position in HARP in Q1 2019 and held it in 4 quarters. The position peaked at $20M in Q3 2019. 53 funds tracked by Wall St. Rank hold HARP as of Q1 2020.

  • EcoR1 Capital reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • EcoR1 Capital sold 90,855 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $13.4M.
  • EcoR1 Capital first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 4 quarters.
  • EcoR1 Capital's Harpoon Therapeutics, Inc. Common Stock position peaked at $20M in Q3 2019.
  • 53 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2020.

Based on EcoR1 Capital's 13F filing for Q1 2020, filed 15 May 2020.